Trefoil factor family 2 expression inhibits gastric cancer cell growth and invasion in vitro via interactions with the transcription factor Sp3.
The trefoil factor family (TFF) is a group of short secretory peptides of gastric mucous neck cells. The loss of TFF2 protein expression enhances gastric inflammation and occurs in gastric cancer. In this study, we examined the effect of TFF2 on gastric cancer cell lines in vitro and characterized the interaction between TFF2 and Sp3, including the mechanisms that mediate this interaction, using genomics and proteomics approaches, as well as genetics techniques, such as RNA interference and gene knockdown. Assays were performed to examine the role of TFF2 and Sp3 in cancer cell proliferation, invasion and migration. We found that TFF2 expression inhibited the proliferation and invasion capacity of gastric cancer cells, and induced apoptosis. TFF2 interacted with the Sp3 protein, as shown by immunoﬂuorescence staining and immunoprecipitation with western blot analysis. Sp3 knockdown in gastric cancer cells antagonized TFF2 antitumor activity. Additionally, TFF2 upregulated the expression of pro-apoptotic proteins, such as Bid, but downregulated the expression of NF-κB and the anti-apoptotic proteins, Bcl-xL and Mcl‑1. By contrast, Sp3 knockdown significantly blocked TFF2 activity, affecting the expression of these proteins. The data from our study demonstrate that the antitumor activity of TFF2 is mediated by an interaction with the Sp3 protein in gastric cancer cells. Additional in vivo and ex vivo warrned in order to fully characterize this interaction.
Department of Gastroenterology, Zhongshan Hospital Affiliated to Xiamen University, Xiamen, Fujian 361004, P.R. China.
Yiling
Y
Cai
Department of Gastroenterology, Zhongshan Hospital Affiliated to Xiamen University, Xiamen, Fujian 361004, P.R. China.
Mengting
M
Yi
Department of Gastroenterology, Zhongshan Hospital Affiliated to Xiamen University, Xiamen, Fujian 361004, P.R. China.
Dajun
D
Chen
Department of Gastroenterology, Zhongshan Hospital Affiliated to Xiamen University, Xiamen, Fujian 361004, P.R. China.
Jingjing
J
Liu
Department of Gastroenterology, Zhongshan Hospital Affiliated to Xiamen University, Xiamen, Fujian 361004, P.R. China.
Bayasi
B
Guleng
Department of Gastroenterology, Zhongshan Hospital Affiliated to Xiamen University, Xiamen, Fujian 361004, P.R. China.
Jianlin
J
Ren
Department of Gastroenterology, Zhongshan Hospital Affiliated to Xiamen University, Xiamen, Fujian 361004, P.R. China.
Huaxiu
H
Shi
D017209:Apoptosis / Q000235:genetics; D051023:BH3 Interacting Domain Death Agonist Protein / Q000378:metabolism; D015153:Blotting, Western; D002460:Cell Line; D045744:Cell Line, Tumor; D002465:Cell Movement / Q000235:genetics; D049109:Cell Proliferation / Q000235:genetics*; D015972:Gene Expression Regulation, Neoplastic; D057809:HEK293 Cells; D006801:Humans; D018715:Microscopy, Video; D064549:Myeloid Cell Leukemia Sequence 1 Protein / Q000378:metabolism; D016328:NF-kappa B / Q000378:metabolism; D009361:Neoplasm Invasiveness; D011485:Protein Binding; D034622:RNA Interference; D051705:Sp3 Transcription Factor / Q000235:genetics* / Q000378:metabolism; D013274:Stomach Neoplasms / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D000071164:Trefoil Factor-2 / Q000235:genetics* / Q000378:metabolism; D051020:bcl-X Protein / Q000378:metabolism
D051023:BH3 Interacting Domain Death Agonist Protein; C579095:MCL1 protein, human; D064549:Myeloid Cell Leukemia Sequence 1 Protein; D016328:NF-kappa B; D000071164:Trefoil Factor-2; D051020:bcl-X Protein; D051705:Sp3 Transcription Factor
Blood. 2015 Mar 19;125(12):1957-67
25538045
PLoS One. 2013 Dec 04;8(12):e80638
24324617
Cell Oncol (Dordr). 2014 Apr;37(2):131-45
24710631
Bosn J Basic Med Sci. 2015 Feb 01;15(1):33-7
25725142
Int J Mol Med. 2009 Feb;23(2):189-96
19148542
Adv Enzyme Regul. 2008;48:189-208
18187045
Am J Respir Cell Mol Biol. 2008 Aug;39(2):243-51
18314536
J Gastroenterol Hepatol. 2008 Aug;23(8 Pt 1):1175-81
18637055
Gastroenterology. 2011 Sep;141(3):837-845.e1-7
21699780
Nat Biotechnol. 2002 May;20(5):497-500
11981564
PLoS One. 2015 Apr 13;10 (4):e0122678
25876034
Int J Cancer. 2009 Aug 1;125(3):666-73
19382179
FASEB J. 2010 Jan;24(1):136-45
19741170
PLoS One. 2013 Dec 31;8(12 ):e83426
24391766
Lancet. 2012 Dec 15;380(9859):2095-128
23245604
FEBS J. 2011 Apr;278(6):964-72
21235713
Gastroenterology. 2010 Dec;139(6):2005-17
20801119
Proc Natl Acad Sci U S A. 2009 Jul 14;106(28):11472-7
19587237
Cancer Res. 2010 Jan 15;70(2):609-20
20068171
J Ethnopharmacol. 2011 Jun 14;136(1):197-203
21549825
Oncogene. 2005 Jan 20;24(4):662-71
15592526
J Biol Chem. 2010 Jun 18;285(25):19162-72
20424169
J Biomed Sci. 2015 Feb 21;22:16
25884934
Am J Physiol Gastrointest Liver Physiol. 2009 Aug;297(2):G385-96
19541923
Cancer Res. 2005 Jul 1;65(13):5864-71
15994964
J Biol Chem. 2014 Oct 3;289(40):27363-75
25124036
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90
21296855
Gene. 2013 Oct 15;529(1):104-12
23933418
World J Gastroenterol. 2010 Jan 21;16(3):330-8
20082478
Oncol Lett. 2014 May;7(5):1525-1531
24765170
Biochem Biophys Res Commun. 2015 Aug 7;463(4):859-63
26056002